Integrated bioinformatics analysis of miRNA expression in Ewing sarcoma and potential regulatory effects of miR-21 via targeting ALCAM/CD166

References

• Bernstein M, Kovar H, Paulussen M, et al. Ewing's sarcoma family of tumours: current management. Oncologist. 2006;11:503–519.
   PubMed Web of Science ®Google Scholar
• Brasme JF, Morfouace M, Grill J, et al. Delays in diagnosis of paediatric cancers: a systematic review and comparison with expert testimony in lawsuits. Lancet Oncol. 2012;13:e445–59.
   PubMed Web of Science ®Google Scholar
• Burchill SA. Ewing's sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities. J Clin Pathol. 2003;56:96–102.
   PubMed Web of Science ®Google Scholar
• Gaspar N, Hawkins DS, Dirksen U, et al. Ewing sarcoma: current management and future approaches through collaboration. Jco. 2015;33:3036–3046.
   PubMed Web of Science ®Google Scholar
• Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17:272–283.
   PubMed Web of Science ®Google Scholar
• Shenoy A, Blelloch RH. Regulation of microRNA function in somatic stem cell proliferation and differentiation. Nat Rev Mol Cell Biol. 2014;15:565–576.
   PubMed Web of Science ®Google Scholar
• Dragomir M, Mafra ACP, Dias SMG, et al. Using microRNA networks to understand cancer. Int J Mol Sci. 2018;19:E1871.
   PubMed Web of Science ®Google Scholar
• Li Z, Yu X, Shen J, et al. MicroRNA expression and its clinical implications in Ewing's sarcoma. Cell Prolif. 2015;48:1–6.
   PubMed Web of Science ®Google Scholar
• Barrett T, Troup DB, Wilhite SE, et al. NCBI GEO: mining tens of millions of expression profiles–database and tools update. Nucleic Acids Res. 2007;35:D760–D765.
   PubMed Web of Science ®Google Scholar
• Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets–update. Nucleic Acids Res. 2012;41:D991–D995.
   PubMed Web of Science ®Google Scholar
• Huang DW, Sherman BT, Tan Q, et al. DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res. 2007;35:W169–W175.
   PubMed Web of Science ®Google Scholar
• Pathan M, Keerthikumar S, Ang CS, et al. FunRich: an open access standalone functional enrichment and interaction network analysis tool. Proteomics. 2015;15:2597–2601.
   PubMed Web of Science ®Google Scholar
• Ohneda O, Ohneda K, Arai F, et al. ALCAM (CD166): its role in hematopoietic and endothelial development. Blood. 2001;98:2134–2142.
   PubMed Web of Science ®Google Scholar
• Grier HE, Krailo MD, Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumour of bone. N Engl J Med. 2003;348:694–701.
   PubMed Web of Science ®Google Scholar
• Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16:203–222.
   PubMed Web of Science ®Google Scholar
• McKinsey EL, Parrish JK, Irwin AE, et al. A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs. Oncogene. 2011;30:4910–4920.
   PubMed Web of Science ®Google Scholar
• De Vito C, Riggi N, Cornaz S, et al. A TARBP2-dependent miRNA expression profile underlies cancer stem cell properties and provides candidate therapeutic reagents in Ewing sarcoma. Cancer Cell. 2012;21:807–821.
   PubMed Web of Science ®Google Scholar
• Zhou X, Chen J, Xiao Q, et al. MicroRNA-638 inhibits cell growth and tubule formation by suppressing VEGFA expression in human Ewing sarcoma cells. Biosci Rep. 2018;38:BSR20171017.
   PubMed Web of Science ®Google Scholar
• Expansion of the gene ontology knowledgebase and resources. Nucleic Acids Res 2017;45:D331–d338.
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Sato Y, Kawashima M, et al. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 2016;44:D457.
   PubMed Web of Science ®Google Scholar
• Eke I, Cordes N. Focal adhesion signaling and therapy resistance in cancer. Semin Cancer Biol. 2015;31:65–75.
   PubMed Web of Science ®Google Scholar
• Pfeffer SR, Yang CH, Pfeffer LM. The role of miR-21 in cancer. Drug Dev Res. 2015;76:270–277.
   PubMed Web of Science ®Google Scholar
• Si ML, Zhu S, Wu H, et al. miR-21-mediated tumour growth. Oncogene. 2007;26:2799–2803.
   PubMed Web of Science ®Google Scholar
• Medina PP, Nolde M, Slack FJ. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature. 2010;467:86–90.
   PubMed Web of Science ®Google Scholar
• Wai Wong C, Dye DE, Coombe DR. The role of immunoglobulin superfamily cell adhesion molecules in cancer metastasis. Int J Cell Biol. 2012;2012:1.
   Google Scholar
• Weidle UH, Eggle D, Klostermann S, et al. ALCAM/CD166: cancer-related issues. Cancer Genom Proteom. 2010;7:231–243.
   PubMedGoogle Scholar
• Willrodt AH, Beffinger M, Vranova M, et al. Stromal expression of activated leukocyte cell adhesion molecule promotes lung tumour growth and metastasis. Am J Pathol. 2017;187:2558–2569.
   PubMed Web of Science ®Google Scholar
• Ye M, Du YL, Nie YQ, et al. Overexpression of activated leukocute cell adhesion molecule in gastric cancer is associated with advanced stages and poor prognosis and miR-9 deregulation. Mol Med Rep. 2015;11:2004–2012.
   PubMed Web of Science ®Google Scholar
• Kahlert C, Weber H, Mogler C, et al. Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse. Br J Cancer. 2009;101:457.
   PubMed Web of Science ®Google Scholar
• Hansen AG, Arnold SA, Jiang M, et al. ALCAM/CD166 is a TGF-beta-responsive marker and functional regulator of prostate cancer metastasis to bone. Cancer Res. 2014;74:1404.
   PubMed Web of Science ®Google Scholar